Cargando…
Extracellular vesicle–based drug delivery in cancer immunotherapy
Extracellular vesicles (EVs) are a group of nanoscale membrane-bound organelles including exosomes, microvesicles (MVs), membrane particles, and apoptotic bodies, which are released from almost all eukaryotic cells. Owing to their ingredients, EVs can be employed as biomarkers for human diseases. In...
Autores principales: | Najafi, Sajad, Majidpoor, Jamal, Mortezaee, Keywan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234250/ https://www.ncbi.nlm.nih.gov/pubmed/37261603 http://dx.doi.org/10.1007/s13346-023-01370-3 |
Ejemplares similares
-
Checkpoint inhibitor/interleukin‐based combination therapy of cancer
por: Mortezaee, Keywan, et al.
Publicado: (2022) -
Anti-PD-(L)1 therapy of non-small cell lung cancer–A summary of clinical trials and current progresses
por: Mortezaee, Keywan, et al.
Publicado: (2023) -
Transforming growth factor‐β signalling in tumour resistance to the anti‐PD‐(L)1 therapy: Updated
por: Mortezaee, Keywan, et al.
Publicado: (2023) -
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
por: Majidpoor, Jamal, et al.
Publicado: (2022) -
CD8(+) T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives
por: Mortezaee, Keywan, et al.
Publicado: (2022)